In cancer cells originating from endometriotic lesions, elevated ROS levels are linked to enhanced proliferative signaling via the PI3K/Akt pathway, often as a consequence of the tumor suppressor PTEN being deactivated [175]. The gene discussed is AKT1; the disease is cancer.